SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon teams up with KGI to train bioscience students

14 Dec 2013 Evaluate

Biocon, Asia’s leading biotechnology enterprise, has teamed up with a top American bioscience institute to train and develop industry-ready talent for India's rapidly growing pharma sector. Biocon’s educational arm - Biocon Academy, in partnership with the California-based Keck Graduate Institute (KGI), will launch the Biocon KGI Certificate Programme in Biosciences next year on January 9.

The 16-week course, offered in Bangalore, will leverage the industry leadership strengths of Biocon and the academic vigour of KGI to benefit participants and make them readily employable.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services.

Biocon Share Price

415.80 -5.90 (-1.40%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: